Why the study?
Observational studies investigating the potential carcinogenic effects of common antihypertensive drug classes have yielded conflicting results.
Do antihypertensive drugs increase the risk of developing cancer?
Comparison
Antihypertensive drugs versus risk of cancer
Design
Review
Authors
Loading...
Conflicting observational data on antihypertensive carcinogenicity urge continued monitoring; leaves open whether any class meaningfully raises cancer risk.
Do antihypertensive drugs increase the risk of developing cancer?
This review summarizes current data on the potential link between antihypertensive drugs and cancer risk.
Sanidas et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: